A Phase I Study of BKM120 With mFOLFOX6 in Patients With Advanced Solid Tumors With Expansion Cohort in Metastatic Pancreatic Cancers
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Buparlisib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Solid tumours
- Focus Adverse reactions
- 01 Jul 2016 Status changed from recruiting to completed.
- 12 Oct 2015 Interim results ( n=17) published in the Investigational New Drugs
- 27 Sep 2013 Official title, inclusion and exclusion criteria amended as reported by ClinicalTrials.gov.